Fit for duty ? no "one size fits all" solution for cannabis testing in the workplace
OTTAWA, Ontario, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Forty-one per cent of organizations have employee alcohol and drug testing protocols in place that are applicable to cannabis. Of these, 91 per cent list fitness for duty?the ability to perform assigned duties without limitations from drug use, fatigue, or other stressors?as a main motivator for testing.
"Testing for cannabis in the workplace is complex, mainly due to the unclear connection between consumption and level of impairment" says Monica Haberl, senior research associate at The Conference Board of Canada. Additionally, the consequences of impairment vary based on the industry or safety level.
About the report
The report examines the human rights legislation on alcohol and drug testing in the workplace, common testing protocols, and different types of testing. It also looks at how responding organizations define a positive test, steps following a positive test, and established protocols in the event of test refusal.
Key Findings from the report:
Cannabis is complex. It is a challenging substance to test for, mainly due to the unclear connection between consumption and level of impairment. To test positive for cannabis means cannabis is present in the body, but it does not necessarily mean the individual is currently impaired.
There is no "one size fits all" policy. Ninety-one per cent of employers are motivated by fitness for duty when it comes to why they test. Although there is a common goal, not all workplaces are equal, and as such, consequences of impairment vary based on the industry or safety level.
There is no perfect test. Employers should implement the testing method that best reflects their alcohol and drug policy. Forty per cent of organizations have a zero-tolerance policy?suggesting urinalysis testing may be most appropriate. Seventy per cent have a fitness-for-duty policy and may want to consider lab-based oral fluid testing.
Alcohol and drug testing should be part of a bigger program. Testing practices should be complemented by resources and support for employees who may have a true substance use disorder, require medical accommodation, or need further education.
-30-
The Conference Board of Canada equips leaders and decision-makers with the economic insights, research, data, networks and events they need to solve our country's most pressing challenges. We stand at the intersection of research, policy and business - where insights meet impact.
Follow The Conference Board of Canada on Twitter @ConfBoardofCda
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...
Product: Kalihim (Philippine Bread Roll)
Issue: Food - Allergen - Egg
Distribution: British Columbia
See the affected products and product photos for this recall
SOURCE Canadian Food Inspection Agency (CFIA)
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...